Form D · Pharmaceuticals
QurAlis Corp
Cambridge, MA · CIK 0001811817
Offering snapshot reported Sep 5, 2025 · SEC filing
- Reported sold
- $20M Offering amount: $24.9M
- Investors reported
- 19 Form D · investor count
- Minimum accepted
- Not reported Reported outside-investor minimum
- First sale
- Aug 21, 2025 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Sep 5, 2025 | Initial | $19,952,387 | No comparison | 19 | SEC filing |
| Mar 13, 2023 | Initial | $59,982,508 | No comparison | 27 | SEC filing |
| Sep 1, 2022 | Initial | $5,000,000 | No comparison | 19 | SEC filing |
| May 18, 2020 | Initial | $33,222,703 | No comparison | 25 | SEC filing |
Offering details
- Securities
- Not reported
- Exemptions
- Not reported
- Duration over one year
- Not reported
- Business combination
- Not reported
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-556816
Source: Form D, filed Sep 5, 2025. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No matching detailed fund disclosure was found in the latest imported ADV filings. This does not establish that the issuer has no adviser.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Jonathan Behr | Director |
| Jason Brown | Executive |
| Roel Bulthuis | Director |
| Hagen Cramer | Executive |
| Laia Crespo Martin | Director |
| Luc Dochez | Director |
| Daniel Elbaum | Executive |
| Jonathan Fleming | Director |
| Johannes Fruehauf | Director |
| Angela Genge | Executive |
| Michael Hutton | Director |
| Cillian King | Director |
| Kasper C.D. Roet | Director, Executive, Promoter |
| Amy Schulman | Director |
| Vikas Sharma | Executive |
| Chris Thomajan | Executive |
| Julio E. Vega | Executive |
| Shafique Virani | Executive |
| Anne Whitaker | Director |
Issuer details
Industry: Pharmaceuticals (See others in industry)
Address:
35 Cambridge Park Drive
Cambridge, MA, 02140
Phone: 781-816-7031
Cambridge, MA, 02140
Phone: 781-816-7031